Page last updated: 2024-10-22

amitriptyline and Disease

amitriptyline has been researched along with Disease in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyer, P1
Guelfi, JD1

Other Studies

1 other study available for amitriptyline and Disease

ArticleYear
[Somatic disorders and depressive states].
    Annales medico-psychologiques, 1978, Volume: 136, Issue:10

    Topics: Amitriptyline; Antidepressive Agents; Cardiovascular Diseases; Depression; Disease; Drug Hypersensit

1978